Paris-based Sanofi said it is moving its focus away from its diabetes R&D efforts, which plays a role in the Onduo joint venture with Verily.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,